Inventaire - your friends and communities are your best library - Inventaire

Reply to Brewer: Liver-targeted ALDH2 inhibition may reduce alcohol-seeking behaviors with limited side effects

author

Adrien Guillot

George Koob

published in: Proceedings of the National Academy of Sciences of the United States of America

date of publication: 2020-03-03

Cites articles 11

Date

Title

Authors

2020-03-03

Partial ALDH inhibition to facilitate controlled drinking rather than abstinence has already been tried and it works

Colin Brewer
2019-01-01

Repurposing Disulfiram as An Anti-Cancer Agent: Updated Review on Literature and Patents
2019-12-02

Targeting liver aldehyde dehydrogenase-2 prevents heavy but not moderate alcohol drinking

Adrien Guillot, Tony Jourdan, George Koob
2018-11-11

Alcohol Dehydrogenases, Aldehyde Dehydrogenases, and Alcohol Use Disorders: A Critical Review

Howard J Edenberg, Jeanette N. McClintick
2014-02-10

Disulfiram efficacy in the treatment of alcohol dependence: a meta-analysis
2012-02-17

Drug targeting to the diseased liver
2012-07

Aldehyde dehydrogenase inhibitors: a comprehensive review of the pharmacology, mechanism of action, substrate specificity, and clinical application

Vasilis Vasiliou
2004-01-01

Does disulfiram have a role in alcoholism treatment today?
2004-01-01

Disulfiram: cautions on liver function; how to supervise
2001-12-01

Mitochondrial injury by disulfiram: two different mechanisms of the mitochondrial permeability transition

Maxim Balakirev
1999-05-01

Safety issues concerning the use of disulfiram in treating alcohol dependence

Article - wd:Q90008822

Welcome to Inventaire

the library of your friends and communities

you are offline